Summit Trail Advisors’s Aimmune Therapeutics, Inc. AIMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-13
Closed 1929
2017
Q4
$0 Buy
+13
New ﹤0.01% 2146